GL1X · GenesisL1 explorer

Ligand · L0F

L0F · N-[3-(1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]benzamide

L0F, N-[3-(1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]benzamide (C17 H13 N5 O, 303.3 g/mol), in the MolNFT structures on GenesisL1: bound in 4 records (2 PDB entries). Every binding site with its residues within 4.5 Å, the residues it binds…

Component
L0F
Formula
C17 H13 N5 O
Class
ligand
Structures
4
PDB entries
2

Binding sites

L0F in 4 structures; the first of them:

  • 2W1F · Structure determination of Aurora Kinase in complex with inhibitor · L0F A1390 · binds ARG137, LEU139, GLY140, LYS141, VAL147, ALA160, LYS162, LEU194 and 9 more
  • 2W1H · Fragment-Based Discovery of the Pyrazol-4-yl urea (AT9283), a Multi- targeted Kinase… · L0F A1299 · binds ILE10, GLY11, GLY13, VAL18, ALA31, VAL64, PHE80, GLU81 and 10 more
  • 2W1F · Structure determination of aurora kinase in complex with inhibitor · L0F A1390 · binds ARG137, LEU139, GLY140, LYS141, VAL147, ALA160, LYS162, LEU194 and 9 more
  • 2W1H · Fragment-based discovery of the pyrazol-4-yl urea (AT9283), a multi-targeted kinase… · L0F A1299 · binds ILE10, GLY11, GLY13, VAL18, ALA31, VAL64, PHE80, GLU81 and 10 more

Residues it binds most

LEU 4, ALA 4, GLY 4, VAL 4, ASP 2, GLN 2, GLU 4, LYS 2, PHE 2, ARG 2 (residue and the binding sites it lines).

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.